Annual Working Capital
$1.41 B
-$595.23 M-29.64%
December 31, 2023
Summary
- As of February 7, 2025, VIR annual working capital is $1.41 billion, with the most recent change of -$595.23 million (-29.64%) on December 31, 2023.
- During the last 3 years, VIR annual working capital has risen by +$739.52 million (+109.83%).
- VIR annual working capital is now -29.64% below its all-time high of $2.01 billion, reached on December 31, 2022.
Performance
VIR Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$930.00 M
-$179.33 M-16.17%
September 30, 2024
Summary
- As of February 7, 2025, VIR quarterly working capital is $930.00 million, with the most recent change of -$179.33 million (-16.17%) on September 30, 2024.
- Over the past year, VIR quarterly working capital has dropped by -$179.33 million (-16.17%).
- VIR quarterly working capital is now -55.83% below its all-time high of $2.11 billion, reached on September 30, 2022.
Performance
VIR Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
VIR Working Capital Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -29.6% | -16.2% |
3 y3 years | +109.8% | -50.4% |
5 y5 years | +1714.2% | -50.4% |
VIR Working Capital Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -29.6% | +15.7% | -55.8% | at low |
5 y | 5-year | -29.6% | +311.0% | -55.8% | +189.6% |
alltime | all time | -29.6% | +1714.2% | -55.8% | +1094.2% |
Vir Biotechnology Working Capital History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $930.00 M(-16.2%) |
Jun 2024 | - | $1.11 B(-0.9%) |
Mar 2024 | - | $1.12 B(-20.8%) |
Dec 2023 | $1.41 B(-29.6%) | $1.41 B(-11.9%) |
Sep 2023 | - | $1.60 B(-6.8%) |
Jun 2023 | - | $1.72 B(-8.1%) |
Mar 2023 | - | $1.87 B(-6.7%) |
Dec 2022 | $2.01 B(+64.4%) | $2.01 B(-4.6%) |
Sep 2022 | - | $2.11 B(+16.3%) |
Jun 2022 | - | $1.81 B(-2.9%) |
Mar 2022 | - | $1.87 B(+52.7%) |
Dec 2021 | $1.22 B | $1.22 B(+46.7%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2021 | - | $832.61 M(+16.2%) |
Jun 2021 | - | $716.27 M(+13.3%) |
Mar 2021 | - | $632.01 M(-6.1%) |
Dec 2020 | $673.30 M(+95.8%) | $673.30 M(-12.8%) |
Sep 2020 | - | $772.57 M(+47.5%) |
Jun 2020 | - | $523.82 M(+63.1%) |
Mar 2020 | - | $321.14 M(-6.6%) |
Dec 2019 | $343.79 M(+341.5%) | $343.79 M(+17.2%) |
Sep 2019 | - | $293.40 M(-12.9%) |
Jun 2019 | - | $336.68 M(+332.3%) |
Dec 2018 | $77.88 M(-56.7%) | $77.88 M |
Dec 2017 | $179.91 M | - |
FAQ
- What is Vir Biotechnology annual working capital?
- What is the all time high annual working capital for Vir Biotechnology?
- What is Vir Biotechnology annual working capital year-on-year change?
- What is Vir Biotechnology quarterly working capital?
- What is the all time high quarterly working capital for Vir Biotechnology?
- What is Vir Biotechnology quarterly working capital year-on-year change?
What is Vir Biotechnology annual working capital?
The current annual working capital of VIR is $1.41 B
What is the all time high annual working capital for Vir Biotechnology?
Vir Biotechnology all-time high annual working capital is $2.01 B
What is Vir Biotechnology annual working capital year-on-year change?
Over the past year, VIR annual working capital has changed by -$595.23 M (-29.64%)
What is Vir Biotechnology quarterly working capital?
The current quarterly working capital of VIR is $930.00 M
What is the all time high quarterly working capital for Vir Biotechnology?
Vir Biotechnology all-time high quarterly working capital is $2.11 B
What is Vir Biotechnology quarterly working capital year-on-year change?
Over the past year, VIR quarterly working capital has changed by -$179.33 M (-16.17%)